Navigating the U.S. Food and Drug Administration's Regulatory Science Initiative: An Imperative for Stem Cell Research and Regenerative Medicine Advocates

Hamburg M. (2009). Newsmaker interview. Margaret Hamburg aims to strengthen FDA science. Interview by Robert Koenig. Science, 325:802.

Institute of Medicine. (2011). Building a National Framework for the Establishment of Regulatory Science for Drug Development: Workshop Summary. The National Academies Press, Washington, DC.

Bhattacharya B , Miura T , Brandenberger R , Mejido J , Luo Y , Yang AX , Joshi BH , Ginis I , Thies RS et al. (2004). Gene expression in human embryonic stem cell lines: unique molecular signature. Blood, 103:2956–2964.

Hutt PB , Merrill RA and Grossman LA (2007). Food and Drug Law, 3rd edn. Foundation Press, New York, pp 2–3.

U.S. Food and Drug Administration. NIH and FDA Announce Collaborative Initiative to Fast-track Innovations to the Public. FDA–NIH News Release, February 24, 2010. www.fda.gov/newsevents/newsroom/pressannouncements/ucm201706.htm

Couzin-Frankel J . FDA's $25 million pitch for improving drug regulation. ScienceInsider, October 7, 2010. http://news.sciencemag.org/funding/2010/10/fdas-25-million-pitch-improving-drug-regulation

Puri RK . Overview: Division of Cellular and Gene Therapies, Office of Cellular, Tissue and Gene Therapies. OCTGT, CBER, FDA, November 29, 2012. www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM341248.ppt

Request for Information (RFI): FDA Collaborating Centers of Excellence in Regulatory Science Innovation (FDA-CERSI). FDA, February 22, 2013. http://grants.nih.gov/grants/guide/notice-files/NOT-FD-13-008.html